Announcements Trials

Browse Landscape

Phase

Phase 2 7 Phase 1 6 Phase 1/2 4 Phase 3 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Diffuse Intrinsic Pontine Glioma 1

Interventions

Cisplatin 294 Radiotherapy 230 Fluorouracil 201 Cyclophosphamide 191 Capecitabine 182 Docetaxel 166 Gemcitabine 165 Oxaliplatin 162 Carboplatin 160 Paclitaxel 152 Leucovorin 122 Drug Therapy 118 Dexamethasone 118 Doxorubicin 112 Etoposide 99 Bevacizumab 91 Cytarabine 87 Vincristine 83 Irinotecan 81 Rituximab 77 Epirubicin 71 Prednisone 65 Radiosurgery 63 Methotrexate 62 Surgical Procedures, Operative 61 Radiation 60 Radiotherapy, Intensity-Modulated 56 Neoadjuvant Therapy 53 Lenalidomide 52 Letrozole 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × TIC10 compound × Clear all

NCT05476939 2026-02-05

BIOMEDE 2

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡